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Previous studies have revealed a high prevalence of posttraumatic stress disorder (PTSD)
in patients with other severe mental disorders, including schizophrenia. However, the
neuropsychological and psychophysical correlates of comorbid PTSD are less exactly
defined. The purpose of the present study was to assess immediate and delayed
memory, attention, visuospatial skills, language, and basic visual information processing
in patients with schizophrenia with or without PTSD. We recruited 125 patients with
schizophrenia and 70 healthy controls matched for visual acuity, age, gender, education,
and socioeconomic status. Twenty-one of patients with schizophrenia exhibited comorbid
PTSD. We administered the Repeatable Battery for the Assessment of Neuropsychological
Status (RBANS) and visual contrast sensitivity tasks for low spatial/high temporal
frequency (0.3 cycle/degree and 18Hz) and high spatial/low temporal frequency (10
cycles/degree and 1Hz) sinusoidal gratings. All patients were clinically stable and received
antipsychotic medications. Results revealed that relative to healthy controls, patients
with schizophrenia exhibited significant and generalized neuropsychological dysfunctions
and reduced visual contrast sensitivity, which was more pronounced at low spatial/high
temporal frequency. When we compared schizophrenia patients with and without PTSD,
we found that patients with comorbid PTSD displayed lower scores for RBANS attention,
immediate and delayed memory, and visuospatial scores. Schizophrenia patients with or
without PTSD displayed similar visual contrast sensitivity. In conclusion, comorbid PTSD
in schizophrenia may be associated with worse neuropsychological functions, whereas it
does not affect basic visual information processing.
Keywords: schizophrenia, posttraumatic stress disorder (PTSD), neuropsychology neuroimaging, vision tests,
psychopathological features
INTRODUCTION
The presence, origin, and clinical characteristics of posttrau-
matic stress disorder (PTSD) in severe mental disorders, such
as schizophrenia, are one of the most controversial issues in
the literature. According to the meta-analysis of Achim et al.
(2011), the prevalence of PTSD in schizophrenia and related psy-
chotic disorders is 12.4%, with a wide confidence interval of
4–20.8%. Comorbid PTSD, which is characterized by upsetting
re-experiencing the traumatic event (e.g., flashbacks and night-
mares), avoidance of thoughts and cues related to the trauma,
emotional numbing, and increased arousal, may be associated
with adverse functioning, lower quality of life, and worse outcome
(Grubaugh et al., 2011). Early trauma may be a pathogenic factor
in the development of both schizophrenia and PTSD, but later
traumatic events after the emergence of schizophrenia may also
lead to PTSD (Schäfer and Fisher, 2011; Matheson et al., 2013).
In this study, we aimed to clarify two aspects of schizophrenia
in relation to comorbid PTSD: early stage visual information
processing and neuropsychological functions. There is a great
deal of evidence that basic low-level vision, such as the detection
of simple luminance-contrast gratings and elementary percep-
tual organization, is impaired in schizophrenia (reviewed by
Javitt, 2009; Silverstein and Keane, 2011; Butler et al., 2012).
Neuropsychological and social cognitive deficits are extensively
documented in schizophrenia, exhibiting a definitive relation-
ship with psychosocial functioning (Green, 2007; Fett et al., 2011;
Keefe and Harvey, 2012). To our knowledge, there have been no
studies investigating visual information processing in schizophre-
nia with comorbid PTSD, and reports on neuropsychological
functions provided inconsistent results because of differences in
methods and patient populations (Goodman et al., 2007; Fan
et al., 2008; Duke et al., 2010; Peleikis et al., 2012). Therefore,
we recruited a large sample of patients with schizophrenia and
screened them for PTSD. We measured visual contrast sensitivity
to characterize low-level perceptual functions and administered a
standard battery of neuropsychological tests assessing immediate
www.frontiersin.org March 2013 | Volume 4 | Article 136 | 1
Halász et al. Neuropsychology and vision in schizophrenia with PTSD
and delayed memory, attention, language, and visuospatial func-
tions. We hypothesized that patients with schizophrenia with
comorbid PTSD (SCZ + PTSD) would display worse visual
and neuropsychological functions compared with schizophre-
nia patients without PTSD (SCZ). The hypothesis of early stage
visual dysfunction was based on meta-analytic evidence revealing
hypoactivation in the occipital cortex in PTSD, but not in other
anxiety disorders (Etkin and Wager, 2007).
MATERIALS AND METHODS
PARTICIPANTS
We enrolled 125 patients with schizophrenia and 70 healthy
controls with a negative family history for mental disorders
at the National Psychiatry Center, Budapest, Hungary. The
diagnosis was based on structured clinical interviews (First
et al., 1996) and medical records. The patients with schizophre-
nia received antipsychotic medications at the time of testing
(risperidone, olanzapine, quetipaine, haloperidol, aripripra-
zole, zuclopenthixol, amisulpride), which were converted to
chlorpromazine-equivalent doses (Woods, 2003). The severity
of the symptoms was characterized by the Brief Psychiatric
Rating Scale (Overall and Gorham, 1962), and the Clinician-
Administered PTSD Scale (CAPS) (Blake et al., 1990).We used the
Four Factor Index of Social Status (Hollingshead, 1975). All par-
ticipants had normal or corrected-to-normal visual acuity. From
the 125 patients with schizophrenia, 21 patients (17%) exhibited
comorbid PTSD (physical assault: n = 11; sexual assault: n = 7;
sudden violent death of a spouse or friend: n = 1; traffic acci-
dent: n = 1; natural disaster: n = 1). In each patient PTSD was
a current, and not a lifetime, comorbid condition. From the
21 SCZ + PTSD individuals, 7 patients (33%) also had major
depressive disorder (MDD), and 4 patients (19%) had current
substance misuse. From the 104 SCZ patients, 15 individuals
(14%) hadMDD, and 16 individuals (15%) had current substance
misuse. The clinical and demographic data are summarized in
Table 1. The study was done in accordance with the Declaration
of Helsinki, and each participant gave written informed consent.
The study was approved by the institutional ethics board.
VISUAL CONTRAST SENSITIVITY
The procedure, which is suitable for the reliable measurement of
visual contrast sensitivity in individuals with less efficient general
cognitive functions, has been described elsewhere (Kogan et al.,
2004; Kéri and Benedek, 2009). We presented vertical sinusoidal
luminance-contrast gratings on a gamma-corrected ViewSonic
PF815 monitor. During visual contrast sensitivity measurements,
the minimal luminance-contrast is measured, which is indispens-
able for the detection of the gratings (Figure 1). The first type
of stimuli had low spatial frequency (SF) and high temporal fre-
quency (TF) (0.3 cycle/degree and 18Hz, respectively), and the
second type of stimuli had high SF and low TF (10 cycles/degree
and 1Hz, respectively). The stimulus area was a circular window
(mean luminance: 31 cd/m2, size: 8◦). The initial Michelson-
contrast was 12%. We used a Yes/No one-up/two-down staircase
procedure (step size: 0.1 log contrast unit). The participants gave
oral responses (grating is seen or not), and the experimenter
entered all responses on the computer keyboard. We used catch
trials to control for spurious responding. The staircase was fin-
ished when the slope and SD of the last 12 trials was less than
the step size. The detection threshold was the mean of the last 12
reversals (for methodological details, see Kogan et al., 2004; Kéri
and Benedek, 2009).
NEUROPSYCHOLOGICAL ASSESSMENT
We used the Repeatable Battery for the Assessment of
Neuropsychological Status (RBANS) battery, which is suitable
Table 1 | Clinical and demographic characteristics.
CONT SCZ SCZ + PTSD
(n = 70) (n = 104) (n = 21)
Male/female 45/25 60/44 9/12
Age (years) 38.6 (9.4) 40.1 (10.2) 39.6 (9.0)
Education (years) 12.3 (3.5) 11.0 (4.2) 11.6 (6.7)
Socioeconomic status 35.6 (8.9) 33.2 (9.3) 32.0 (10.5)
BPRS – 42.4 (6.3) 45.2 (7.4)
Number of hospitalizations – 4.9 (2.5) 5.1 (3.6)
Age at onset (years) – 23.6 (5.2) 24.7 (6.1)
Chlorpromazine-equivalent
antipsychotics (mg/day)
– 364.4 (192.4) 380.9 (173.1)
CAPS—Re-experiencing – – 17.9 (9.6)
CAPS—Avoidance – – 21.6 (8.7)
CAPS—Arousal – – 22.1 (8.4)
Data are mean (standard deviation) with the exception of gender ratio. CONT,
controls; SCZ, schizophrenia; PTSD, posttraumatic stress disorder; BPRS, brief
psychiatric rating scale; CAPS, clinician-administered PTSD scale. The three
groups did not differ in age, education, and socioeconomic status (p > 0.1,
t-test). In the SCZ + PTSD group, females were overrepresented, although it
was not significant compared with the other two groups (chi-square test, p >
0.05). SCZ and SCZ + PTSD patients did not differ in total BPRS scores (p > 0.1).
FIGURE 1 | Illustration of the principle of contrast sensitivity
measurements. The spatial frequency of a grating is reduced when the
cycles (vertical bars with high and low luminance) under 1◦ is decreased.
Contrast is reduced in a staircase procedure to the minimum level that can
be detected by the participant. The inverse of this threshold is sensitivity.
Temporal frequency is the contrast reversal of the grating (Hz).
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for rapid and comprehensive evaluation of neurocognitive func-
tions (Randolph, 1998; Gold et al., 1999; Juhász et al., 2003).
The RBANS battery consists of 12 tests, combined to five index
scores. Each index score is standardized (normal mean: 100,
SD = 15 based on a normative study group of 200 healthy
Hungarian volunteers, 20–80 years of age). The index domains
are as follows: (1) immediate memory [word list learning
(10 words repeated in four trials), story recall in two trials];
(2) language (confrontation naming of 10 pictures, category
fluency); (3) visuospatial functions (figure copy, line orien-
tation); (4) attention (digit span, digit-symbol coding); (5)
delayed memory (delayed recall of the story, complex figure,
and word list, recognition of the word list). The RBANS bat-
tery has two psychometrically matched forms; here we used
version “A.”
DATA ANALYSIS
We used STATISTICA 11 (StatSoft, Inc., Tulsa) for data analy-
sis. Data quality assumptions were evaluated with Kolmogorov–
Smirnov test (normality of distribution) and Levene’s tests
(homogeneity of variance). Analyses of variance (ANOVAs) were
used in the case of contrast sensitivity and RBANS data, fol-
lowed by Tukey Honestly Significant Difference (HSD) tests,
corrected for unequal sample sizes. We used two-tailed t-tests and
chi-square tests for the comparison of demographic data. The
relationship among the relevant variables was investigated using
Pearson’s product moment correlation coefficients (r). Where
appropriate and informative, we also calculated Cohen’s effect
size values (d). The level of statistical significance was set at
α < 0.05.
RESULTS
VISUAL CONTRAST SENSITIVITY
The ANOVA conducted on the contrast sensitivity data indicated
significant main effects of group [F(2, 192) = 95.47, p < 0.0001],
stimulus type [F(1, 192) = 208.83, p < 0.0001], and a Two-Way
interaction between group and stimulus type [F(2, 192) = 10.83,
p < 0.001]. The post-hoc comparisons revealed that both SCZ
and SCZ + PTSD groups exhibited reduced contrast sensitivity
at low SF/high TF relative to healthy controls (p < 0.001), but
there was no significant difference between the SCZ and SCZ +
PTSD groups (p = 0.74). At high SF/lowTF, the results were simi-
lar (CONT> SCZ= SCZ+ PTSD; significant difference between
CONT and SCZ groups: p < 0.001) (Figure 2). The Two-Way
interaction between group and stimulus type appeared because
the difference between patients (SCZ plus SCZ + PTSD) and
controls was larger on the low SF/high TF condition (d = 1.47)
than on the high SF/low TF condition (d = 0.83).
NEUROPSYCHOLOGICAL PERFORMANCE
Figure 3 demonstrates the RBANS performance. The statisti-
cal analyses (One-Way ANOVAs followed by Tukey HSD for
unequal Ns and Cohen’s effect size values) are summarized in
Table 2. Overall, SCZ patients exhibited significant deficits in
attention, memory, visuospatial functions, and language. Patients
with SCZ + PTSD showed more severe dysfunctions in attention,
memory, and visuospatial functions relative to the SCZ group.
FIGURE 2 | Visual contrast sensitivity. CONT, control; SCZ, schizophrenia;
PTSD, posttraumatic stress disorder; SF, spatial frequency; TF, temporal
frequency. Error bars indicate 95% confidence intervals. SCZ and SCZ +
PTSD patients showed similar reductions in sensitivity relative to controls
(p < 0.001, Tukey HSD for unequal Ns).
FIGURE 3 | Neuropsychological results. CONT, control; SCZ,
schizophrenia; PTSD, posttraumatic stress disorder; RBANS, Repeatable
Battery for the Assessment of Neuropsychological Status; Att, attention;
MemI, immediate memory; MemD, delayed memory; VisSpat, visuospatial;
Lang, language. Error bars indicate 95% confidence intervals. For statistical
details, see Table 2.
CORRELATIONS AND GENDER DIFFERENCES
Correlations among RBANS, contrast sensitivity, symptoms
(BPRS and CAPS scores), and chlorpromazine-equivalent
antipsychotic dose did not reach the level of statistical significance
when SCZ and SCZ + PTSD patients were analyzed separately
or together (−0.1 < r < 0.1, p > 0.1). There were no signifi-
cant differences in any visual perceptual and neuropsychological
measures between male and female patients (p > 0.1, t-tests).
EFFECT OF COMORBID MDD AND SUBSTANCE MISUSE
We compared SCZ and SCZ + PTSD patients with and without
MDD/substance misuse on visual contrast sensitivity and RBANS
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Table 2 | Neuropsychological results.
RBANS
domain
F df p Tukey HSD (unequal Ns)
and Cohen’s effect size (d)
Attention 34.83 2.192 <0.0001 CONT > SCZ > SCZ + PTSD
d[CONT−SCZ] = 0.92
d[CONT−SCZ+PTSD] = 1.47
d[SCZ−SCZ+PTSD] = 0.75
Immediate
memory
52.59 2.192 <0.0001 CONT > SCZ > SCZ + PTSD
d[CONT−SCZ] = 1.13
d[CONT−SCZ+PTSD] = 1.68
d[SCZ−SCZ+PTSD] = 1.0
Delayed
memory
73.51 2.192 <0.0001 CONT > SCZ > SCZ + PTSD
d[CONT−SCZ] = 1.58
d[CONT−SCZ+PTSD] = 1.72
d[SCZ−SCZ+PTSD] = 0.70
Visuospatial
functions
34.59 2.192 <0.0001 CONT > SCZ > SCZ + PTSD
d[CONT−SCZ] = 0.87
d[CONT−SCZ+PTSD] = 1.50
d[SCZ−SCZ+PTSD] = 0.93
Language 8.79 2.192 <0.001 CONT > SCZ = SCZ + PTSD
d[CONT−SCZ] = 0.53
d[CONT−SCZ+PTSD] = 0.88
d[SCZ−SCZ+PTSD] = 0.35
The table present results from One-Way ANOVAs. RBANS, Repeatable Battery
for the Assessment of Neuropsychological Status; CONT, healthy controls; SCZ,
schizophrenia; PTSD, posttraumatic stress disorder. See also Figure 2.
performance. We did not find significant differences between
patients with and without MDD/substancemisuse in the SCZ and
SCZ + PTSD groups (ANOVAs, p > 0.4).
DISCUSSION
The results of the present study indicate that SCZ + PTSD is
associated with more severely disrupted memory, attention, and
visuospatial functions compared with SCZ. In contrast, low-level
visual processing is not affected by the presence of comorbid
PTSD, which suggests that occipital hypoactivation observed in
PTSD may not affect basic contrast processing (Etkin and Wager,
2007). In order to examine visual processing in more detail,
patients with PTSD should be tested with the parallel application
of psychophysical and neuroimaging techniques.
By the assessment of elderly individuals, Goodman et al.
(2007) demonstrated that Holocaust survivor SCZ + PTSD
patients scored lower on tests of speed of information processing,
recognition memory, and general mental status than elderly SCZ
patients without trauma exposure. Lysaker et al. (2001) found
that individuals with schizophrenia-spectrum disorders with self-
reported childhood sexual abuse performed worse in the case
of working memory and executive functions than did individ-
uals without self-reported abuse. Fan et al. (2008) also found a
more severe generalized cognitive dysfunction in SCZ + PTSD
than in SCZ, with a special reference to attention, working mem-
ory, and executive functions. However, two studies failed to find
any evidence that SCZ + PTSD is associated with substantially
increased neuropsychological impairment (Duke et al., 2010;
Peleikis et al., 2012), although in the Duke et al. (2010) study
SCZ + PTSD patients showed a qualitatively different neuropsy-
chological profile compared with SCZ patients, which was influ-
enced by differences in age, education, and symptoms. In the
present study, we identified a relatively high number of SCZ +
PTSD patients, which is consistent with the literature (Achim
et al., 2011). SCZ + PTSD and SCZ patients displayed similar
clinical and demographic characteristics, and, therefore, differ-
ences in neuropsychological performance cannot be attributed
to these potential confounding variables. Comorbid MDD and
substance misuse did not affect neuropsychological and visual
performance. Correlation analysis also revealed negative results
as regards symptoms and antipsychotic medications. A categor-
ical comparison of symptom severity (mild, moderate, severe) is
not possible because studies rarely use CAPS to characterize PTSD
severity in schizophrenia.
Contrary to the differences in neuropsychological functions,
SCZ + PTSD and SCZ patients demonstrated statistically indis-
tinguishable visual contrast sensitivity deficits; in both groups,
reduction in sensitivity was similar relative to controls, which
was more pronounced at low SF/high TF. Several previous stud-
ies demonstrated altered visual contrast sensitivity in SCZ, but
the data varied regarding the specific values measured at different
SFs and TFs (e.g., Slaghuis, 1998; Kéri et al., 2002; Chen et al.,
2003; Butler et al., 2009; Kiss et al., 2010; for a critical review,
see Skottun and Skoyles, 2007, 2011). A more pronounced reduc-
tion in contrast sensitivity at low SF/high TF can be explained by
the differential impairment of the magnocellular visual pathway,
which project from the retina to the primary visual cortex via the
lateral geniculate nucleus; this pathway participates in the pro-
cessing of stimuli with low SF/high TF (Merigan and Maunsell,
1990). However, the magnocellular origin of contrast sensitivity
alteration in SCZ has been debated (Skottun and Skoyles, 2007,
2011) because the magnocellular system shows a considerable
overlap with other cells in the visual system regarding contrast
and SF response. Nevertheless, evidence suggests that the corti-
cal processing of low SFs is compromised in SCZ (Martínez et al.,
2008; Kéri et al., 2012; Calderone et al., 2013), and that low SF
achromatic gratings activate the putative magnocellular layers of
the human lateral geniculate nucleus (Denison et al., 2012). The
rapid development of high-resolution imaging techniques capa-
ble of identifying and visualizing the magnocellular layers may
provide answer to this debate question.
The most important limitation of the present study is that
no PTSD patients without SCZ were included. Therefore, it is
not clear how PTSD itself affects neuropsychological and particu-
larly visual functions in our study context. By conducting a direct
comparison between SCZ + PTSD and PTSD alone, Duke et al.
(2010) demonstrated much milder neuropsychological deficits in
PTSD relative to PTSD + SCZ. Nevertheless, several studies have
shown that PTSD itself is associated with compromised atten-
tion, memory, and executive functions (Golier and Yehuda, 2002),
although the causal link between trauma and impaired cogni-
tion is controversial (Danckwerts and Leathem, 2003). Regarding
low-level vision, even less information is available in PTSD.
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Hendler et al. (2003) showed that the visual cortex displayedmore
activation in PTSD when trauma-related images were exposed at
below recognition threshold, which suggests that the earliest stage
of visual information processing is corrupted in PTSD. However,
it remains to be explored how PTSD patients react to emotion-
ally neutral basic andmore complex visual stimuli (e.g., Levy-Gigi
and Kéri, 2012).
The second limitation was that we had to restrict the assess-
ment of the symptoms, and we did not depict positive, negative,
disorganized, and affective symptom separately. In general, how-
ever, BPRS and CAPS scores did not correlate with neuropsy-
chological and visual contrast sensitivity performance. Finally,
the sample size was still small in the SCZ + PTSD group,
which may limit the generalizability of the findings, given
that the symptoms, clinical course, and outcome of the illness
show a high degree of individual variability and heterogeneity.
Therefore, the results must be replicated and extended in a larger
sample.
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